Covis Group to buy AMAG Pharmaceuticals for $498m

This article was originally published here

The deal is valued at around $647m on an enterprise basis, including debt obligations expected to be assumed or repaid net of cash. As per terms of the

The post Covis Group to buy AMAG Pharmaceuticals for $498m appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply